Panbela Therapeutics Inc (PBLA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PBLA Annual Balance Sheets →
A period-by-period view of the balance sheet from Panbela Therapeutics Inc to Sep 30 2023 helps clarify how Sep 30 2024's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent0.14
Deposits Assets, Current AS4.59
Cash & Short-term Investments4.00
Income Taxes Receivable, Current NO0.33
Other Current Assets0.00
Prepaid Expense, Current AS0.11
Total Current Assets5.17
Other Assets, Noncurrent0.00
Total Assets5.17
Liabilities
Accounts Payable, Current AC10.95
Accrued Liabilities, Current5.47
Notes Payable, Current NO2.20
Other Liabilities, Current1.52
Total Current Liabilities20.14
Long-term debt3.19
Other Long-term Debt, Current OT0.00
Total Long-term Debt3.19
Total Liabilities23.34
Stockholders' Equity
Treasury Stock Common Value0.00
Common Stock Value0.01
Additional Paid In Capital Common Stock128.22
Retained Earnings / Accumulated Deficit-146.94
Other Equity0.54
Common Stockholder's Equity-18.17
Total Stockholder's Equity-18.17
Liabilities & Stockholder's Equity5.17
4 historic quarters locked

Sign in to unlock the full Panbela Therapeutics Inc balance sheet history.

About Panbela Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-24-035315

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.